Genitourinary Cancer
News
Prostate cancer screening fell in wake of trial results, task force recommendations
Major finding: PSA screening increased significantly until March 2009 (P less than .001), then decreased significantly until May 2012 (P less than...
News
I-125 brachytherapy for prostate cancer linked to small increase in bladder cancer risk
Major Finding: Of 1,805 consecutive patients, 170 (10.8%) had second primary malignancies diagnosed at least 1 year after I-125 brachytherapy...
News
No benefit from androgen deprivation therapy in localized prostate cancer
Major finding: Men with localized prostate cancer who deferred curative treatment but opted for primary androgen deprivation therapy saw no...
News
The push for smaller, smarter cancer trials
News
Positive surgical margins do not independently predict prostate cancer mortality
Major finding: Positive surgical margins were not significantly associated with prostate cancer–specific mortality within 15 years of radical...
News
Prostatectomy found superior to watchful waiting over long term
Major finding: In the prostatectomy group, 18-year all-cause mortality was 56.1% and prostate cancer–specific mortality was 17.7%, which are...
News
Prostate cancer death rate highest in Montana
News
Beta-blockers linked to lower mortality in high-risk prostate cancer
Major finding: Beta-blocker use was associated with reduced prostate cancer mortality (adjusted subhazard ratio, 0.79; 95% confidence interval, 0....
News
IMDC model is validated in setting of second-line targeted therapy
Major finding: Compared with patients in the favorable IMDC risk group, patients in the intermediate-risk group and patients in the high-risk...
News
At least a third of low-risk cancers get upgraded at prostatectomy
Major finding: Even though these "low-risk" cases met stringent criteria for active surveillance according to several different protocols, 33%-45...
News
Cytoreductive nephrectomy has selective survival benefit in mRCC
Major Finding: Cytoreductive nephrectomy significantly prolonged adjusted survival only among patients with a life expectancy exceeding 12 months...